Patents by Inventor Yuanzhi CHEN

Yuanzhi CHEN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Publication number: 20250101083
    Abstract: The present invention relates to the field of molecular virology and immunology, in particular to the field of hepatitis B virus (HBV) infection treatment. In particular, the present invention relates to an epitope peptide (or a variant thereof) capable of treating a hepatitis B virus infection, a recombinant protein comprising the epitope peptide (or a variant thereof) and a carrier protein, and an antibody (e.g. a nanobody) for the epitope peptide. The epitope peptide and antibody of the present invention can be used to prevent and/or treat HBV infection or a disease related to HBV infection (e.g. hepatitis B), for reducing the serum level of HBV DNA and/or HBsAg in a subject (e.g. a human), or for activating a subject (e.g. a chronic HBV infected person or a chronic hepatitis B patient) against HBV humoral immune response.
    Type: Application
    Filed: January 20, 2023
    Publication date: March 27, 2025
    Inventors: Wenxin LUO, Yue WANG, Yaxian MEI, Zhenghong AO, Yuanzhi CHEN, Jixian TANG, Yichao JIANG, Xiaoqing CHEN, Tianying ZHANG, Quan YUAN, Ningshao XIA
  • Publication number: 20230235055
    Abstract: Provided herein are antibodies binding to LILRB1 and the uses of the antibodies in detecting and treating cancer and autoimmune diseases.
    Type: Application
    Filed: July 26, 2021
    Publication date: July 27, 2023
    Applicant: THE BOARD OF REGENTS OF THE UNIVERSITY OF TEXAS SYSTEM
    Inventors: Zhiqiang AN, Chengcheng ZHANG, Ningyan ZHANG, Yuanzhi CHEN, Heyu CHEN